ZA896231B - Heparin fragments and fractions with anti-hiv action - Google Patents

Heparin fragments and fractions with anti-hiv action

Info

Publication number
ZA896231B
ZA896231B ZA896231A ZA896231A ZA896231B ZA 896231 B ZA896231 B ZA 896231B ZA 896231 A ZA896231 A ZA 896231A ZA 896231 A ZA896231 A ZA 896231A ZA 896231 B ZA896231 B ZA 896231B
Authority
ZA
South Africa
Prior art keywords
fractions
heparin fragments
hiv action
hiv
action
Prior art date
Application number
ZA896231A
Other languages
English (en)
Inventor
Henricus Carl Josep Ottenheijm
Carl Joseph Ottenheij Henricus
Franciscus Cornelius Hollander
Cornelius Den Holla Franciscus
Erik Desire Alice De Clercq
Desire Alice De Clercq Erik
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA896231B publication Critical patent/ZA896231B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA896231A 1988-08-24 1989-08-15 Heparin fragments and fractions with anti-hiv action ZA896231B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802087 1988-08-24

Publications (1)

Publication Number Publication Date
ZA896231B true ZA896231B (en) 1990-05-30

Family

ID=19852794

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896231A ZA896231B (en) 1988-08-24 1989-08-15 Heparin fragments and fractions with anti-hiv action

Country Status (13)

Country Link
EP (1) EP0355905B1 (de)
JP (1) JPH02108624A (de)
KR (1) KR0143084B1 (de)
AT (1) ATE84217T1 (de)
AU (1) AU617850B2 (de)
CA (1) CA1330305C (de)
DE (1) DE68904264T2 (de)
DK (1) DK416089A (de)
ES (1) ES2053953T3 (de)
IE (1) IE61565B1 (de)
NZ (1) NZ230394A (de)
PT (1) PT91524B (de)
ZA (1) ZA896231B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (de) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Zusammensetzung zur Hemmung der Thromboseentstehung
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
AU2002214886A1 (en) * 2000-11-09 2002-05-21 Contrimmune Biotechnology Inc Therapeutic uses for IP3 receptor-mediated calcium channel modulators
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (de) * 2005-04-21 2006-11-15 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
WO2011002027A1 (ja) 2009-07-03 2011-01-06 テイ・エス テック株式会社 乗物用シート
MX2013002556A (es) 2010-09-14 2013-05-28 Hoffmann La Roche Polipeptido de fusion de dedo de serpina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
AU4426289A (en) * 1988-10-05 1990-05-01 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
IE61565B1 (en) 1994-11-16
IE892565L (en) 1990-02-24
PT91524B (pt) 1995-07-18
KR900002788A (ko) 1990-03-23
DE68904264T2 (de) 1993-05-27
DK416089D0 (da) 1989-08-23
AU617850B2 (en) 1991-12-05
NZ230394A (en) 1997-02-24
CA1330305C (en) 1994-06-21
PT91524A (pt) 1990-03-08
KR0143084B1 (ko) 1998-07-15
JPH02108624A (ja) 1990-04-20
AU4001289A (en) 1990-03-01
EP0355905B1 (de) 1993-01-07
ES2053953T3 (es) 1994-08-01
DE68904264D1 (de) 1993-02-18
DK416089A (da) 1990-02-25
ATE84217T1 (de) 1993-01-15
EP0355905A1 (de) 1990-02-28

Similar Documents

Publication Publication Date Title
ZA896231B (en) Heparin fragments and fractions with anti-hiv action
IE873245L (en) Administering a deoxythymidine
ZA885577B (en) A pharmaceutical combination product and the preparation and use thereof
EP0311107A3 (de) Anti-HIV-aktive 3'-Fluoro-purin-2',3'-dideoxyriboside
AU3852989A (en) Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
AU620218B2 (en) Anti-hiv drug
EP0325768A3 (en) Non-reverting rna viruses
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
IL81568A0 (en) Plasmids which inhibit human t-cell lymphotropic virus type iii replication
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
AU7512287A (en) Expression of human t-cell lymphotropic virus (htlv-iii)reve rse transcriptase and uses thereof
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
EP0316592A3 (de) 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung
EP0308977A3 (en) Anthracycline derivatives having inhibitory activity against reverse transcriptase of human immunodeficiency virus
IL144382A0 (en) HIV-1 MUTATIONS SELECTED FOR BY β-2',3'-DIDEHYDRO-2',3-DIDEOXY-5-FLUROCYTIDINE
Bryson Genital herpes in adolescents and young adults
FI883735A7 (fi) Ihmisen immuunikatoviruksen, tyyppi 1, antigeenien valmistus ja käyttö diagnostisena ja terapeuttisena välineenä
AU3713489A (en) Non-reverting rna viruses
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
EP0308724A3 (en) Treatment of human immunodeficiency virus using immunostimulating biologic
CA2032748A1 (en) Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo